Related Experiment Video
Updated: Jul 21, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Place of Death of Cancer Patients Treated at a German Comprehensive Cancer Center
Julia Berendt1, Maria Heckel1, Christoph Ostgathe1
1Department of Palliative Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Centres, CCC Erlangen-EMN, Comprehensive Cancer Centres Alliance WERA (CCC WERA), Bavarian Cancer Research Centres (BZKF), Erlangen, Germany.
Background:
Public health research includes end-of-life care. Place of death is an indicator of end-of-life care quality.
Objective:
We assessed the place of death of cancer patients treated at a Comprehensive Cancer Center (CCC), caring for an average of 2220 primary cases per year.
Methods:
Dataset includes information on cancer patients who were treated at least once in a German CCC, died between 2009 and 2013, and for whom a place of death could be assigned. Data-reported following the "REporting of Studies Conducted Using Observational Routinely Collected Data" guideline-were retrieved from death registration and analyzed retrospectively. Descriptive analyses, frequency calculations, Pearson/Cramer's V chi-square tests, and t tests in SPSS 28.0 were used.
Results:
A total of 5855 patients were analyzed (metastases n = 2830, 48.3%; recurrent cancer n = 1930, 33.1%). Finally, 3523 (60.2%) died in a clinical setting (CCC: 28.9%/other hospital: 31.3%). Patients who died in the CCC (mean age 66.3 years) were younger than those who died in other hospitals (mean age 67.8 years; p = 0.034) or at home (ø 70.2 years; p = 0.000). Cancer patients who died in the CCC (n = 1693) had over time a median of 356 contacts with specialized palliative care within 30 days before death (standard deviation [SD]: 319-377, mean 352). One-third of patients died within one year of diagnosis (p < 0.001). For patients dying in the CCC, the rate was even higher (50.6%, p < 0.001).
Conclusion:
Even if treated in certified centers, CCC cancer patients have a high in-hospital mortality rate. The place of death reflects care structures and disease progression, highlighting the need for palliative care. As frequent death sites, CCCs should offer specialized palliative services. Further research is needed to better align the place of death with patient wishes.
Related Concept Videos
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer Survival Analysis

